Key facts
- This page summarizes Alfred Lloyd Bowie Jr.'s Form 3 filing for Eikon Therapeutics, Inc. (EIKN).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2026, 21:34.
Alfred Lloyd Bowie Jr. - 04 Feb 2026 Form 3 Insider Report for Eikon Therapeutics, Inc. (EIKN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- EIKN
- Reported as of
- 04 Feb 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 04 Feb 2026, 21:34:18 UTC
- Next SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Benjamin Thorner, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alfred Lloyd Bowie Jr. filed Form 3 for Eikon Therapeutics, Inc. (EIKN) on 04 Feb 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002104152
Primary reporting owner
Bowie Alfred Lloyd Jr.
- Relationship
- Chief Financial Officer
- Address
- C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE
- Signature
- /s/ Benjamin Thorner, Attorney-in-Fact
- Signature date
- 04 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EIKN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 51,572
- Date
- 04 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EIKN
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 55,698
- Exercise price
- $1.94
- Footnotes
- F1
EIKN
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33,521
- Exercise price
- $9.85
- Footnotes
- F2
EIKN
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,147
- Exercise price
- $9.85
- Footnotes
- F2
EIKN
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 63,691
- Exercise price
- $9.85
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
One-fourth of the shares underlying the option vest on the one year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each date.
Footnote F2
The shares underlying the option will vest in equal monthly installments for four years after the vesting starting date, subject to the Reporting Person's continued service through each date.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney